Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

June 2, 2015

Genentech’s Investigational Cobimetinib Extends Progression-Free Survival

News

Updated data from Genentech’s Phase 3 clinical trial of patients with BRAF V600 mutation-positive advanced melanoma treated with cobimetinib (an investigational MEK inhibitor) in combination with Zelboraf® (vemurafenib) show that ... Read more

May 13, 2015May 13, 2015

DNA Repair Mapped by UNC Researchers

Melanoma, News

Groundbreaking work in mapping damaged DNA repair in the human genome reached a milestone at the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center. The new ... Read more

April 29, 2015April 29, 2015

β-catenin Protein Activators Found to be Effective Against Melanoma Cells

Melanoma, News

A variety of therapeutic options for melanoma have been developed since 2011, changing the way advanced melanomas are treated. Some treatments focus on specific mutations found in melanoma patients, such as ... Read more

March 5, 2015March 5, 2015

Oleocanthal in Olive Oil Pokes Holes in Cancer Cells

News, Skin Cancer

Working in a laboratory at Rutgers University, Drs. Paul Breslin, David Foster, and Onica LeGendre discovered how a chemical component of olive oil kills human cancer cells derived from skin ... Read more

January 15, 2015January 15, 2015

Metastatic Melanoma in Mice Treated with ALS Therapeutic and Radiation

Melanoma, News

Melanoma that has metastasized to the brain may be more effectively treated using radiation therapy in combination with the drug riluzole than with radiation alone. Researchers at Rutgers Cancer Institute ... Read more

January 12, 2015January 12, 2015

Genetic Test for Melanoma Metastasis from Castle Biosciences Validated in Recent Study

Melanoma, News

A recent study published in Clinical Cancer Research, “Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma,” used Texas-based Castle Bioscience’s DecisionDx-Melanoma test for cutaneous ... Read more

January 8, 2015January 8, 2015

Melanoma Pigmentation Linked to Mitochondrial ROS Levels

Melanoma, News

A new study from The Medical School of Newcastle University is assigning guilt by association to mitochondrial function and melanoma. Melanoma skin cancer cells that display high levels of pigmentation ... Read more

November 26, 2014November 26, 2014

Study Finds Key Mutations in Melanoma Patients Responsive to Immunotherapy

Melanoma, News

Timothy Chan, MD, PhD, and oncology fellow Alexandra Snyder Charen, MD, at the Memorial Sloan Kettering Cancer Center, are working to advance the way melanoma patients are treated with immunotherapy. The ... Read more

November 12, 2014

Tumor Thickness Indicates 10-Year Survival for Mucosal Melanoma

Melanoma, News

When thinking of melanoma, skin cancer due to ultraviolet radiation usually comes to mind. Less commonly, about 1% of melanoma patients can develop mucosal melanoma, which is associated with a ... Read more

October 29, 2014

Metastasectomies Following Systemic Treatment Discussed in Panel

Melanoma, News

Surgery following systemic therapy against melanoma is a widely discussed topic in the world of clinical oncology. OncLive, a platform of information concerning cancers that include lung, leukemia, and melanoma, ... Read more

October 20, 2014October 20, 2014

Melanoma Patients Often Carry TERT Promoter Mutations

Melanoma, News

A group at University Hospital Essen in German confirmed the commonality of mutations in the gene for telomerase reverse transcriptase (TERT) in patients with cutaneous melanoma through a new study ... Read more

October 17, 2014October 17, 2014

SIRT6 Is Not Protective In Skin Cancer

News, Skin Cancer

“One cancer’s threat is another cancer’s promoter” is the theme of a new study published in Cancer Research by the laboratory of Yu-Ying He, PhD, in the Department of Medicine, ... Read more

October 15, 2014October 15, 2014

Melanoma Cells Use LPA Gradient to Migrate Around Body

Melanoma, News

As melanoma is one of the fastest spreading, aggressive cancer types, researchers are constantly trying to understand melanoma cells in order to stop their spread in the body. At the ... Read more

October 14, 2014October 14, 2014

Understanding Mutations, micro-RNAs, and Melanoma at Toldeo University

Melanoma, News, Skin Cancer

At University of Toledo, the laboratories of Drs. Kam Yeung and Ivana de la Serna discovered a new explanation for aggressive melanoma. Ila Datar, a PhD graduate student in the ... Read more

October 9, 2014October 9, 2014

Studies Suggest Efficacy of Intralesional Injections for Melanoma Therapy

News

Three presentations during the “Melanoma and Other Skin Tumors” poster session at the European Society for Medical Oncology (ESMO) 2014 Congress in Madrid highlighted the efficacy of treating cutaneous melanoma ... Read more